* indicates required field
Length: 1
Source of Standard: NAACCR
Section Name: Stage/Prognostic Factors
Year Implemented: 2018
Version Implemented: 18
Record Types: A, M, C, I
XML NAACCR ID: progesteroneRecepSummary
Parent XML Element: Tumor
Required Status:
NPCR Collect: RS - Required, site specific
CoC Collect: RS - Required, site specific
SEER Collect: RS - Required, site specific
CCCR Collect: RS* - Required, site specific; when available
Description:
PR (Progesterone Receptor) Summary is a summary of results from the progesterone receptor (PR) assay.
Rationale:
This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 48, Breast. It was previously collected as Breast CS SSF # 2.
Item Data Type:
digits
Allowable Values
0, 1, 7, 9
Codes:
0 |
PR negative (0.0% or less than 1%) |
|---|---|
1 |
PR positive |
7 |
Test ordered, results not in chart |
9 |
Not documented in medical record |
Code Notes:
Note 1: Physician statement of PR (Progesterone Receptor) Summary status can be used to code this data item when no other information is available.
Note 2: The result of the PR test performed on the primary breast tissue is to be recorded in this data item.
Note 3: Results from nodal or metastatic tissue may be used ONLY when there is no evidence of primary tumor.
Note 4: In cases where PR is reported on more than one breast tumor specimen, record the highest value. If any sample is positive, record as positive.
• Exception: If PR is positive on an in situ specimen and PR is negative on all tested invasive specimens, code PR as negative (code 0).
Note 5: If neoadjuvant therapy is given, record the assay from tumor specimens prior to neoadjuvant therapy.
• If neoadjuvant therapy is given and there are no PR results from pre-treatment specimens, report the findings from post-treatment specimens.
Note 6: If the patient is PR positive and node negative, a multigene test such as Oncotype Dx may be performed, in which case another PR test will be performed. Do not record the results of that test in this field.
• Record only the results of the test which made the patient eligible to be given the multigene test.
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.